Coagulation, inflammation and myocardial dysfunction in unstable coronary artery disease and the influence of glycoprotein IIb/IIIa inhibition and low molecular weight heparin

Myocardial Dysfunction ◽

Low Molecular Weight ◽

Randomized trial of low molecular weight heparin (enoxaparin) vs. unfractionated heparin for unstable coronary artery disease: 1-year results of the ESSENCE study

ACC Current Journal Review ◽

10.1016/s1062-1458(00)00161-6 ◽

2001 ◽

Vol 10 (1) ◽

pp. 15 ◽

Cited By ~ 1

Author(s):

S.G. Goodman ◽

M. Cohen ◽

F. Bigonzi

Keyword(s):

Coronary Artery Disease ◽

Molecular Weight ◽

Coronary Artery ◽

Unfractionated Heparin ◽

Randomized Trial ◽

Low Molecular Weight ◽

Low molecular weight heparin (dalteparin) in the management of unstable coronary artery disease (FRIC)

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(96)82352-7 ◽

1996 ◽

Vol 27 (2) ◽

pp. 359

Author(s):

W. Klein

Keyword(s):

Coronary Artery Disease ◽

Molecular Weight ◽

Coronary Artery ◽

Low Molecular Weight ◽

Effects of low-molecular-weight heparin treatment on fibrinolytic markers in unstable coronary artery disease

Fibrinolysis and Proteolysis ◽

10.1054/fipr.2001.0100 ◽

2001 ◽

Vol 15 (1) ◽

pp. 26-31 ◽

Cited By ~ 1

Author(s):

H. Toss ◽

L. Wallentin ◽

A. Siegbahn

Keyword(s):

Coronary Artery Disease ◽

Molecular Weight ◽

Coronary Artery ◽

Low Molecular Weight ◽

Heparin Treatment ◽

Low-Molecular-Weight Heparin and Other Antithrombotic Agents in the Setting of a Primarily Medical Treatment of Unstable Coronary Artery Disease

Pathophysiology of Haemostasis and Thrombosis ◽

10.1159/000054177 ◽

2000 ◽

Vol 30 (2) ◽

pp. 122-127

Author(s):

Freek W.A. Verheugt

Keyword(s):

Coronary Artery Disease ◽

Molecular Weight ◽

Coronary Artery ◽

Medical Treatment ◽

Low Molecular Weight ◽

Antithrombotic Agents ◽

Randomized trial of low molecular weight heparin (enoxaparin) versus unfractionated heparin for unstable coronary artery disease∗∗∗∗A list of participating ESSENCE Study Group investigators may be found in N Engl J Med 1997;337:447–52.

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(00)00808-1 ◽

2000 ◽

Vol 36 (3) ◽

pp. 693-698 ◽

Cited By ~ 100

Author(s):

Shaun G Goodman ◽

Marc Cohen ◽

Frederique Bigonzi ◽

David R Radley ◽

Gregg J Fromell ◽

...

Keyword(s):

Coronary Artery Disease ◽

Molecular Weight ◽

Coronary Artery ◽

Unfractionated Heparin ◽

Randomized Trial ◽

Low Molecular Weight ◽

Study Group ◽

Reduction of myocardial damage by prolonged treatment with subcutaneous low molecular weight heparin in unstable coronary artery disease

European Heart Journal ◽

10.1053/euhj.1998.1339 ◽

1999 ◽

Vol 20 (9) ◽

pp. 645-652 ◽

Cited By ~ 6

Author(s):

H SATRE

Keyword(s):

Coronary Artery Disease ◽

Molecular Weight ◽

Coronary Artery ◽

Myocardial Damage ◽

Prolonged Treatment ◽

Low Molecular Weight ◽

A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Unstable Coronary Artery Disease

New England Journal of Medicine ◽

10.1056/nejm199708143370702 ◽

1997 ◽

Vol 337 (7) ◽

pp. 447-452 ◽

Cited By ~ 981

Author(s):

Marc Cohen ◽

Christine Demers ◽

Enrique P. Gurfinkel ◽

Alexander G.G. Turpie ◽

Gregg J. Fromell ◽

...

Keyword(s):

Coronary Artery Disease ◽

Molecular Weight ◽

Coronary Artery ◽

Unfractionated Heparin ◽

Low Molecular Weight ◽

A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease

Air Medical Journal ◽

10.1016/s1067-991x(98)90098-0 ◽

1998 ◽

Vol 17 (1) ◽

pp. 37

Keyword(s):

Coronary Artery Disease ◽

Molecular Weight ◽

Coronary Artery ◽

Unfractionated Heparin ◽

Low Molecular Weight ◽

Low molecular weight heparin in unstable coronary artery disease

Expert Opinion on Investigational Drugs ◽

10.1517/13543784.9.3.581 ◽

2000 ◽

Vol 9 (3) ◽

pp. 581-592 ◽

Cited By ~ 10

Author(s):

Lars Wallentin

Keyword(s):

Coronary Artery Disease ◽

Molecular Weight ◽

Coronary Artery ◽

Low Molecular Weight ◽

A critical review of clinical trials for low-molecular-weight heparin therapy in unstable coronary artery disease

Clinical Cardiology ◽

10.1002/clc.4960240715 ◽

2001 ◽

Vol 24 (7) ◽

pp. 492-499 ◽

Cited By ~ 5

Author(s):

Steen Husted ◽

Richard Becker ◽

Andre Kher

Keyword(s):

Coronary Artery Disease ◽

Molecular Weight ◽

Clinical Trials ◽

Coronary Artery ◽

Critical Review ◽

Heparin Therapy ◽

Low Molecular Weight ◽